EPIFOAM (MEDA Pharmaceuticals)


Welcome to the PulseAid listing for the EPIFOAM drug offered from MEDA Pharmaceuticals. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MEDA Pharmaceuticals
NON-PROPRIETARY NAME: pramoxine hydrochloride and hydrocortisone acetate
SUBSTANCE NAME: PRAMOXINE HYDROCHLORIDE; HYDROCORTISONE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: AEROSOL, FOAM
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-08-25
END MARKETING DATE: 0000-00-00


EPIFOAM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEPIFOAM from MEDA Pharmaceuticals
LABELER NAME: MEDA Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 100; 100(mg/10g; mg/10g)
START MARKETING DATE: 2014-08-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-6824_b22b8b40-2f1e-11e4-8c21-0800200c9a66
PRODUCT NDC: 0037-6824
APPLICATION NUMBER: ANDA086457

Other PRAMOXINE HYDROCHLORIDE; HYDROCORTISONE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Meda PharmaceuticalsPROCTOFOAM
MEDA PharmaceuticalsEPIFOAM